IPO registrations (S-1, F-1) · Registrants
Exscientia plc
- SEC CIK
- 1865408 · filings on EDGAR ↗
- Name on the registration
- Exscientia Ltd
- Former names
- Exscientia Ltd (2021–2021)
- Registration
- Form F-1, first filed 2021-09-10, last 2021-09-27; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-10-04; declared effective 2021-09-30
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- X0
- Business address
- THE SCHRODINGER BUILDING, OXFORD SCIENCE PARK, Oxford, X0 OX4 4GE
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $20.00–$22.00 per ADS (F-1/A filed 2021-09-27)
- Final price
- $22.00 per ADS, within the range (424B4 filed 2021-10-04, an initial public offering)
- Shares sold
- 13,850,000
- Gross proceeds
- $304,700,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol EXAI
- Lead underwriters
- Goldman Sachs (4,847,500 shares); Morgan Stanley (4,847,500 shares); BofA Securities (2,770,000 shares); Barclays (1,385,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-09-10 | F-1 | F-1 (foreign registration) | Exscientia Ltd | 0001104659-21-114491 ↗ |
| 2021-09-17 | F-1/A | F-1/A (amendment) | Exscientia Ltd | 0001104659-21-116988 ↗ |
| 2021-09-27 | F-1/A | F-1/A (amendment) | Exscientia Ltd | 0001104659-21-119607 ↗ |
| 2021-09-30 | F-1MEF | F-1MEF (added securities) | Exscientia Ltd | 0001104659-21-121448 ↗ |
| 2021-09-30 | EFFECT | EFFECT (declared effective) | Exscientia Ltd | 9999999995-21-003720 ↗ |
| 2021-09-30 | EFFECT | EFFECT (declared effective) | Exscientia Ltd | 9999999995-21-003725 ↗ |
| 2021-10-04 | 424B4 | 424B4 (final prospectus) | Exscientia Ltd | 0001104659-21-122290 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-27 | F-1/A | registration statement | $20.00–$22.00 | $21.00 | 13,095,238 | $274,999,998 | Nasdaq EXAI | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2021-10-04 | 424B4 | final prospectus | $22.00 | 13,850,000 | $304,700,000 | Nasdaq EXAI | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), X0 first:
- Abcam plc X0
- Immunocore Holdings plc X0
- Autolus Therapeutics plc X0
- Orchard Therapeutics plc X0
- Freeline Therapeutics Holdings plc X0
- Achilles Therapeutics plc X0
- Gyroscope Therapeutics Holdings plc X0
- OKYO Pharma Ltd X0
- TC BioPharm (Holdings) plc X0
- BioNTech SE 2M
In other datasets, the same topic (Health) in X0:
- Form D issuer: Abcam plc (Form D private offerings)
Interests: Biological Products, (No Diagnostic Substances) · Health